American College of Clinical Pharmacy
      Search      Cart
         
ACCP Report

Johnson, Marken, Nutescu, and Polk to Receive ACCP Honors

ACCP members Julie Johnson, Pharm.D., FCCP, BCPS; Patricia Marken, Pharm.D., FCCP, BCPP; Edith Nutescu, Pharm.D., FCCP; and Ronald Polk, Pharm.D., have been selected by the College’s Awards Committee to receive the association’s prestigious 2009 Therapeutic Frontiers Lecturer, Education, Clinical Practice, and Russell R. Miller Awards, respectively. The awards will be presented in Anaheim, California, on Sunday morning, October 18, during the Opening General Session of the College’s 2009 Annual Meeting.

Julie A. Johnson, Pharm.D., FCCP, BCPS
Julie A. Johnson

The ACCP Therapeutic Frontiers Lecture Award recognizes an individual, including ACCP member and nonmember nominees, who has made outstanding contributions to pharmacotherapeutics in his or her field. Among the criteria for this award is the broad acknowledgment that the recipient is currently considered to be at the leading edge of research in the field. Julie Johnson is the V. Ravi Chandran Professor of Pharmaceutical Sciences, Professor and Chair of the Department of Pharmacotherapy and Translational Research, Professor of Pharmaceutics and Professor of Medicine (Cardiovascular Medicine) at the University of Florida Colleges of Pharmacy and Medicine, and Director, University of Florida Center for Pharmacogenomics. She is internationally recognized for her work on cardiovascular drug pharmacogenomics and the influence of race and ethnicity on drug response. Dr. Scott Weiss, Director of Harvard University’s Center for Genomic Medicine, wrote in his letter of support for Dr. Johnson’s nomination,

She is an individual who has made an outstanding contribution to pharmacotherapeutics in her chosen field of pharmacogenetics of antihypertensive therapy. She has done innovative research that has direct therapeutic applications and she is at the leading edge of her field. Her work has had an impact on pharmacotherapy and she is one of a very small group of pharmacists who are competing at an international level with regard to her research.

Dr. John Pieper, Dean and Professor at the University of New Mexico College of Pharmacy, noted in his letter supporting Dr. Johnson,

Her publications have played a critical role in elucidating the role of ethnicity in response to cardiovascular drugs, in the application of pharmacogenomics to optimizing cardiovascular drug therapy, and in the use of pharmacogenetic data in explaining the results of large scale clinical cardiovascular trials. She serves as one of only three individuals holding the Pharm.D. degree who serve as the Principal Investigator for a Pharmacogenetics Research Network Center.

Dr. Johnson’s lecture, titled “Cardiovascular Pharmacogenomics: From DNA to the Clinic,” will be delivered at 10:30 a.m. during Sunday morning’s Opening General Session.

Patricia A. Marken, Pharm.D., FCCP, BCPP
Patricia A. Marken

The Education Award recognizes an ACCP member who has made substantial and outstanding contributions to clinical pharmacy education at either the undergraduate or the postgraduate level. Patricia Marken is Professor of Pharmacy Practice in the School of Pharmacy and Professor of Psychiatry in the School of Medicine at the University of Missouri–Kansas City (UMKC). Having served as a faculty member for more than 20 years, Dr. Marken has distinguished herself as a dedicated and innovative educator and leader. Letters written by colleagues in support of Dr. Marken’s nomination speak to her track record of translating educational methodology into innovative course delivery. One of her nominators wrote,

She has clearly been a lifelong leader among the faculty in developing courses that actively involve our students and prepare them for their professional careers. As longtime chair of the pharmacy school’s curriculum committee, Dr. Marken has been instrumental in organizing our curriculum to include activities that emphasize problem-solving, communication skills, professionalism, and contemporary practice.

Adds a colleague,

Dr. Marken is committed to the success of junior members in our profession—a hallmark trait of an outstanding educator. In addition to the numerous students, residents, and fellows she has guided over the years, she has successfully mentored many junior faculty members through the rigorous promotion and tenure process.

In her capacity as Chair of the UMKC Division of Pharmacy Practice between 1999 and 2008, Dr. Marken “nurtured a desire for excellence in educating our students across our entire division,” noted a colleague. “The excellence of the educational environment here at the school of pharmacy is largely attributable to Dr. Marken, either directly or as a result of her influence.” Also devoted to scholarship, Dr. Marken has written more than 40 peer-reviewed articles, over 20 book chapters, and numerous other publications. She is a past Chair of the ACCP CNS PRN, a board-certified psychiatric pharmacist, and a Fellow of the College.

Edith A. Nutescu, Pharm.D., FCCP
Edith A Nutescu

The ACCP Clinical Practice Award is given to a College member who has made substantial and outstanding contributions to clinical pharmacy practice. The criteria considered in identifying potential candidates include exceptional leadership in the development of innovative clinical pharmacy services and sustained excellence in providing them. Edith Nutescu is Clinical Associate Professor of Pharmacy Practice, Director of the Antithrombosis Center, and an affiliate faculty member in the Center for Pharmacoeconomic Research at the University of Illinois at Chicago (UIC) College of Pharmacy. Dr. Nutescu was responsible for establishing the Antithrombosis Center at the UIC Medical Center in 1996 and for developing it into one of the most well-recognized antithrombosis programs in the world. Of note, the UIC Antithrombosis Clinic was one of only two sites visited by the Joint Commission on Accreditation of Health Care Organizations (JCAHO) during its study of new accreditation standards for anticoagulation clinics. In recommending Dr. Nutescu, one of her nominators pointed to her stature as a leader in anticoagulation therapeutics, noting that she “is the first non-physician to serve as Vice President of the Anticoagulation Forum” as well as “the only pharmacist member of the National Quality Forum’s National Steering Committee for the Prevention and Care of Venous Thromboembolism.” In addition, Dr. Nutescu has served on NIH expert panels, the National Consumer League’s Oral Anticoagulant Advisory Board, and the editorial boards of several professional journals. One of her colleagues emphasized in his letter of support for Dr. Nutescu’s nomination, “Edith has been—and will continue to be—an exemplary role model for clinical pharmacists who aspire to excellence in clinical practice and she is an outstanding ambassador for pharmacy to other disciplines.” Despite maintaining an active practice, she regularly contributes to the medical and pharmacy literature. Dr. Nutescu’s scholarship, focused on antithrombotic therapy and clinical pharmacy services, includes more than 70 peer-reviewed articles or book chapters and over 50 papers presented at national and international meetings.

Ronald E. Polk, Pharm.D.
Ronald E. Polk

Russell R. Miller was the founding editor of the College’s journal, Pharmacotherapy. The Russell R. Miller Award is presented in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy. Ronald Polk is Professor of Pharmacy and Medicine and Chairman of the Department of Pharmacy at Virginia Commonwealth University/Medical College of Virginia. A leading authority in infectious diseases and antimicrobial therapy, he has made sustained contributions to this area of therapeutics with particular emphasis on the pharmacokinetics and pharmacodynamics of anti-infectives. Most recently, Dr. Polk’s research has focused on microbial resistance and inappropriate antibiotic use. His body of work includes numerous peer-reviewed publications, including research papers, reviews, book chapters, and commentaries. One of his nominators commented on Dr. Polk’s seminal work on the red man syndrome associated with vancomycin.

He was among the first to describe the vancomycin red man syndrome, to confirm the role of histamine in its pathogenesis and to emphasize to practicing physicians that this syndrome was not a hypersensitivity phenomenon that would necessitate drug discontinuation but rather a side effect easily mitigated by altering infusion timing and pretreating with antihistamine.

Another colleague commented on Dr. Polk’s sustained contributions to the clinical pharmacy discipline, “As one of the 29 founding members of ACCP, Dr. Polk shared a vision of advancing cutting-edge clinical pharmacy practice and research.” Indeed, his expertise is widely recognized by his peers in medicine—Dr. Polk is one of only a handful of pharmacists to have written a chapter in Mandell, Douglas, and Bennett’s Principles & Practice of Infectious Diseases and Harrison’s Principles of Internal Medicine (a text for which he has written a chapter in every edition published since 1994), and he is among the first pharmacists to have been inducted as a Fellow in the Infectious Diseases Society of America. During the past 30 years, he has educated and trained many clinical pharmacy fellows, pharmacy and medical residents, and students in a variety of health disciplines. Dr. Polk’s editorial and peer review contributions include service as a member of the Pharmacotherapy editorial board for more than 15 years and appointment as a contributing editor to Antimicrobial Agents and Chemotherapy.